The Targets of Immune Adverse Events in Cancer Immunotherapy by Combined Check-Point Inhibitors Resemble Those Seen in Ipex Patients
                        AuthID
P-01A-87F
                
    P-01A-87F
© 2025 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service